Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases, today announced Avalyn management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference in New York City on September 14, 2026, at 1:50-2:25 p.m. ET.
Covered in this story
What has happened since
- Morgan Stanley is down 12.0% since this was published, 27 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Morgan Stanley
- Morgan Stanley: $216 → $215 by Jul 2027 via GuruFocus
- RBC Capital Markets: $211 → $243 by Jul 2027 · Sector Perform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Morgan Stanley →Dalsna Finance is currently tracking 54 stories mentioning Morgan Stanley, the earliest published 23 Mar 2026.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.